Suchergebnisse - "Motahari, Rasoul"

PubPharm (11)

1

Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors : Design, synthesis, bioactivity evaluation, and in silico studies

enthalten in: Bioorganic chemistry | 2023

von Hasanvand, Z. | Oghabi Bakhshaiesh, T. | Peytam, F. | +15

2

Thienopyrimidine-based agents bearing diphenylurea : Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity

enthalten in: Archiv der Pharmazie | 2023

von Mohammadian, E. | Oghabi Bakhshaiesh, T. | Jouyban, A. | +10

3

Thienopyrimidine‐based agents bearing diphenylurea : Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity

enthalten in: Archiv der Pharmazie | 2023

von Mohammadian, E. | Oghabi Bakhshaiesh, T. | Jouyban, A. | +10

4

Design, synthesis and evaluation of novel tetrahydropyridothienopyrimidin-ureas as cytotoxic and anti-angiogenic agents

enthalten in: Scientific reports | 2022

von Motahari, R. | Boshagh, M. | Moghimi, S. | +9

5

Novel 3-aminobenzofuran derivatives as multifunctional agents for the treatment of Alzheimer's disease

enthalten in: Frontiers in chemistry | 2022

von Hasanvand, Z. | Motahari, R. | Nadri, H. | +6

6

Quinazolin-4(3H)-one based agents bearing thiadiazole-urea : Synthesis and evaluation of anti-proliferative and antiangiogenic activity

enthalten in: Bioorganic chemistry | 2021

von Faraji, A. | Motahari, R. | Hasanvand, Z. | +10

7

Corrigendum to "Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis" [Eur. J. Med. Chem 209 (2021) 112942

enthalten in: European journal of medicinal chemistry | 2021

von Faraji, A. | Oghabi Bakhshaiesh, T. | Hasanvand, Z. | +8

ErratumFor: Eur J Med Chem. 2021 Jan 1;209:112942. - PMID 33328104

8

Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis

enthalten in: European journal of medicinal chemistry | 2021

von Faraji, A. | Oghabi Bakhshaiesh, T. | Hasanvand, Z. | +8

ErratumIn: Eur J Med Chem. 2021 Mar 15;214:113228. - PMID 33550180

9

Gap junction blockers : a potential approach to attenuate morphine withdrawal symptoms

enthalten in: Journal of biomedical science | 2013

von Moradi, S. | Charkhpour, M. | Ghavimi, H. | +3

10

Gap junction blockers: a potential approach to attenuate morphine withdrawal symptoms

enthalten in: Journal of biomedical science | 2013

von Moradi, S. | Charkhpour, M. | Ghavimi, H. | +3